400 HOWARD STREET,
SAN FRANCISCO , CA, 94105
SAN FRANCISCO , CA, 94105
Summary
The fund seeks to provide access to companies with innovative healthcare exposure, by investing in companies across any size in the United States.
The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.
Next, the research team invests significantly in pharmaceutical and biotechnology co More
Webiste
Directors
Oct 13, 2023- John E. Kerrigan
- Richard L. Fagnani
- Robert S. Kapito
- Drew E. Lawton
- John E. Martinez
- Salim Ramji
- Madhav V. Rajan
- Jane D. Carlin
- Cecilia H. Herbert
Chief Compliance Officer
- Aaron Wasserman
Price
- $ 34.14 ( +0 )
-
Aug 29, 2022Last Close
- Net Assets
-
$36.8M
Sep 27, 2022
- 52-Week High/Low
- $0 - $0
- Expense Ratio
- -
Performance
YTD
0%
3 Year
38.7%
5 Year
0%
Best
193.09%
2005
Worst
-66.81%
2006
Company Name |
Holding |
| Johnson & Johnson | 10.24 % |
| BLACKROCK CASH FUNDS TREASURY SL AGENCY SHARES | 7.73 % |
| Eli Lilly & Co | 7.55 % |
| AbbVie Inc | 6.08 % |
| Merck & Co Inc | 5.77 % |
| Bristol-Myers Squibb Co | 5.36 % |
| Vertex Pharmaceuticals Inc | 5.13 % |
| Moderna Inc | 4.5 % |
| Amgen Inc | 4.38 % |
| Gilead Sciences Inc | 4.01 % |
| More | 4.01 % |
NAV
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IEIH | 0% | 0% | 0% | -3.7% | -55.5% | 185.1% | 19% | 0% | 67.7% | -6.5% | |
| S&P 500 | -8.3% | 23.3% | 24.2% | -19.4% | 27.3% | 16.2% | 28.9% | -6.2% | 19.4% | 9.5% |
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| q1 | 0% | 0% | 0% | -3.4% | -81.2% | -9.3% | 10.8% | 0% | 0% | 0% | ||||
| q2 | 0% | 0% | 0% | -3.9% | 20.1% | 18.2% | -1.9% | 7.1% | 0% | 0% | ||||
| q3 | 0% | 0% | 0% | 3.7% | -4.2% | -19.6% | -5.8% | 12.2% | 0% | 0% | ||||
| q4 | 0% | 0% | 0% | 0% | 4.5% | 231% | 15.4% | -13.2% | 0% | 0% |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 2024 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |